APA
Ivashchenko A. V., Iamanushkin P. M., Mit'kin O. D., Ezhova E. V., Korzinov O. M., Shevkun N. A., Koriakova A. G., Karapetian R. N., Bychko V. V., Ivashchenko A. A., Agrba V. Z., Lapin B. A. & Orlov S. V. (20140904). [Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]. : Eksperimental'naia i klinicheskaia farmakologiia.
Chicago
Ivashchenko A V, Iamanushkin P M, Mit'kin O D, Ezhova E V, Korzinov O M, Shevkun N A, Koriakova A G, Karapetian R N, Bychko V V, Ivashchenko A A, Agrba V Z, Lapin B A and Orlov S V. 20140904. [Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]. : Eksperimental'naia i klinicheskaia farmakologiia.
Harvard
Ivashchenko A. V., Iamanushkin P. M., Mit'kin O. D., Ezhova E. V., Korzinov O. M., Shevkun N. A., Koriakova A. G., Karapetian R. N., Bychko V. V., Ivashchenko A. A., Agrba V. Z., Lapin B. A. and Orlov S. V. (20140904). [Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]. : Eksperimental'naia i klinicheskaia farmakologiia.
MLA
Ivashchenko A V, Iamanushkin P M, Mit'kin O D, Ezhova E V, Korzinov O M, Shevkun N A, Koriakova A G, Karapetian R N, Bychko V V, Ivashchenko A A, Agrba V Z, Lapin B A and Orlov S V. [Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]. : Eksperimental'naia i klinicheskaia farmakologiia. 20140904.